Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · page 39 of 44
The chart uses a split-axis design to represent three distinct study phases (0169, 0170 OL, 0170 RW).
Conference presentation · before_after · analyze_data · balanced density
Slide locked Sign in to view
Slide schematic 4/4
chart 1/1 disclaimer 1/1 legend 1/1 title 1/1
Components 4
line disclaimer legend headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1